Evidence-based recommendations of postoperative radiotherapy in lung cancer from Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)

• A. Gómez ^[4] ; J. A. González ^[5] ; F. Couñago ^[6] ; C. Vallejo ^[1] ; F. Casas ^[2] ; N. Rodríguez de Dios ^[3]
  1. [1] Hospital Ramón y Cajal

     Hospital Ramón y Cajal

     Madrid, España

     
  2. [2] Hospital Clinic Barcelona

     Hospital Clinic Barcelona

     Barcelona, España

     
  3. [3] Hospital de la Esperanza

     Hospital de la Esperanza

     Barcelona, España

     
  4. [4] Hospital Universitario Santiago de Compostela, España
  5. [5] Instituto Oncológico Cartuja, Unidad Regional de Sevilla, España
  6. [6] Hospital Universitario Quirón Madrid, España

  Mostrar afiliaciones +
• Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 18, Nº. 4 (April 2016), 2016, págs. 331-341
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Locally advanced non-small cell lung cancer (NSCLC) is a diversified illness in which postoperative radiation therapy (PORT) for complete resection with positive hiliar (pN1) and/or mediastinal (pN2) lymph nodes is controversial. Although several studies have shown that PORT has beneficial effects, randomized trials are needed to demonstrate its impact on overall survival. In this review, the Spanish Radiation Oncology Group for Lung Cancer describes the most relevant literature on PORT in NSCLC patients stage pN1–2. In addition, we have outlined the current recommendations of different national and international clinical guidelines and have also specified practical issues regarding treatment volume definition, doses and fractionation.